Statements of Cash Flows Statement - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities:
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest	$ (7,844,000)	$ (2,709,000)
Reconciliation of net loss to net cash provided by (used in) operating activities:
Depreciation expense	38,161,000	45,827,000
Amortization of above and below Market Leases	(1,369,000)	(1,399,000)
Deferred fee income amortization	(1,449,000)	(1,195,000)
amortization of purchase option termination fee income	0	(1,229,000)
Deferred Sales Inducement Cost, Amortization Expense	1,628,000	1,229,000
Deferred loan cost amortization	1,566,000	1,609,000
deferred interest income	(1,531,000)	(2,822,000)
Receipt of accrued interest income on real estate loans	0	3,109,000
Gain (Loss) on Disposition of Assets	0	(798,000)
Gains (Losses) on Sales of Investment Real Estate	(22,000)	0
Gain (Loss) From Unconsolidated Joint Ventures	108,000	194,000
cash inflows purchase option terminations	0	1,479,000
Loss on extinguishment of debt	363,000	0
Provision for Loan and Lease Losses	572,000	522,000
Changes in operating assets and liabilities:
(Increase) in tenant accounts receivable	(3,445,000)	4,766,000
Increase (Decrease) in Accounts Payable and Accrued Liabilities	(429,000)	(2,787,000)
Increase in accounts payable and accrued expenses	1,874,000	2,589,000
Net cash provided by (used in) operating activities	28,227,000	48,385,000
Investing activities:
Investments in real estate loans	(13,605,000)	(18,840,000)
Proceeds from Principal Repayments on Loans and Leases Held-for-investment	0	17,925,000
Deferred real estate loan income	0	79,000
Acquisition of properties, net	(90,203,000)	(289,000)
Payments to Acquire Property, Plant, and Equipment	(260,000)
Disposition of properties and proceeds from land sales, net		(4,798,000)
Proceeds from Divestiture of Interest in Joint Venture	(2,718,000)	0
Payments to Acquire Investments	(4,875,000)	(10,263,000)
Net cash (used in) investing activities	(111,661,000)	(6,590,000)
Financing activities:
Proceeds from mortgage notes payable	106,310,000	2,152,000
Extinguishment of Debt, Amount	(61,745,000)	(10,340,000)
Payments for mortgage loan costs	(589,000)	(285,000)
Payments of Debt Issuance Costs	(324,000)	0
Proceeds from non-revolving lines of credit	185,000,000	105,000,000
Payments on revolving lines of credit	(185,000,000)	(87,000,000)
Proceeds from sales of Units, net of offering costs	2,800,000	34,109,000
Proceeds from Issuance of Common Stock	(19,162,000)	(40,018,000)
Proceeds from Warrant Exercises	179,213,000	0
Dividends declared and paid	(9,382,000)	(8,829,000)
Payments of Ordinary Dividends, Preferred Stock and Preference Stock	(27,118,000)	(33,840,000)
Payments for deferred offering costs, net of non cash items	(1,143,000)	(1,030,000)
Proceeds from Noncontrolling Interests	2,625,000
Payments of Ordinary Dividends, Noncontrolling Interest	(236,000)	(56,000)
Net Cash Provided by (Used in) Financing Activities	171,249,000	(40,137,000)
Net increase in cash, cash equivalents and restricted cash	87,815,000	1,658,000
Cash beginning of period	62,880,000	75,716,000
Cash end of period	150,695,000	77,374,000
Supplemental cash flow information:
Cash paid for interest	21,660,000	25,231,000
Supplemental disclosure of non-cash investing and financing activities:
Accrued capital expenditures	4,349,000	3,756,000
Dividends, Common Stock	11,379,000	9,087,000
Dividends, Preferred Stock	10,130,000	11,323,000
Reclass of offering costs from deferred asset to equity	2,506,000	647,000
Share-based Compensation	$ 5,052,000	$ 6,168,000